HOME
WHO IS BDA
BDA DELIVERS
KEY PROJECTS
REFERENCE WORK 
PRINCIPALS & ASSOCIATES
CONTACT US 
Business Development Advisors
Reference Work

CardioDynamics International Corporation's (NASDAQ: CDIC) primary product, the BioZ.com®, uses proprietary Impedance Cardiography (ICG) technology to noninvasively assess a patient's hemodynamics, data which typically has been available only through a time-consuming, costly, and potentially dangerous invasive procedure called Pulmonary Artery Catheterization (PAC), or the Swan Ganz Catheter. BioZ's ICG monitoring is noninvasive and can be performed in outpatient areas such as physician offices, which have never before had access to hemodynamic information in treating heart failure, hypertension, pacemaker, and dialysis patients. In hospitals, BioZ monitoring on surgical or intensive care patients can decrease costs through the elimination of procedure risk, reduction of hospital stay, and minimization of hospital expenditures and personnel. BioZ can also provide hemodynamic information in areas where previously it has not been available, such as emergency departments, step-down units, dialysis, and labor and delivery.

How Sourced: Potential Acquirer

Our involvement: Due Diligence, pricing, business model, acquisition and valuation strategy, management sourcing.